10x Genomics, Inc. (TXG)

10x Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	432.51	344.07	359.28	219.75	587.45	663.6
Short-Term Investments	49.58	49.34	29.41	210.24	-	-
Cash & Short-Term Investments	482.08	393.4	388.7	429.98	587.45	663.6
Cash Growth	21.08%	1.21%	-9.60%	-26.80%	-11.48%	56.45%
Receivables	96.59	87.86	114.83	104.21	85.25	51.21
Inventory	61.96	83.11	73.71	81.63	59.97	29.96
Prepaid Expenses	19.2	20.02	18.79	16.58	13.9	13.03
Restricted Cash	-	-	-	2.63	1.03	16.57
Total Current Assets	659.83	584.39	596.02	635.04	747.59	774.37
Property, Plant & Equipment	296.18	309.94	344.93	359.21	230.41	119.82
Goodwill	4.51	4.51	4.51	4.51	4.51	-
Other Intangible Assets	64.76	15.67	16.62	22.86	25.4	22.35
Other Long-Term Assets	2.08	4.13	3.06	7.37	10.92	12.8
Total Assets	1,027	918.64	965.14	1,029	1,019	929.34
Accounts Payable	18.07	12.91	15.74	21.6	17.35	4.71
Accrued Expenses	48.19	52.07	45.98	51.9	53.27	35.09
Current Portion of Leases	10.54	9.29	11.52	9.04	5.13	5.94
Current Income Taxes Payable	5.59	4.94	5.05	4.08	4.62	8.65
Current Unearned Revenue	22.14	20.66	13.15	7.87	5.34	4.47
Other Current Liabilities	42.8	17.77	35.73	36.48	24.64	59.27
Total Current Liabilities	147.32	117.63	127.16	130.96	110.36	118.13
Long-Term Leases	76.44	73.33	83.85	86.14	76.85	57.04
Long-Term Unearned Revenue	10.87	12.51	8.81	3.17	-	-
Other Long-Term Liabilities	7.6	5.03	4.28	2.98	14.05	15.1
Total Liabilities	242.24	208.5	224.1	223.24	201.26	190.27
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	2,279	2,178	2,026	1,839	1,681	1,544
Retained Earnings	-1,494	-1,467	-1,284	-1,029	-863.32	-805.1
Comprehensive Income & Other	0.14	-0.49	-0.43	-4.34	0.02	-0.05
Total Common Equity	785.12	710.13	741.04	805.74	817.57	739.07
Shareholders' Equity	785.12	710.13	741.04	805.74	817.57	739.07
Total Liabilities & Equity	1,027	918.64	965.14	1,029	1,019	929.34
Total Debt	86.99	82.61	95.37	95.18	81.98	62.98
Net Cash (Debt)	395.1	310.79	293.33	334.81	505.47	600.63
Net Cash Growth	26.52%	5.95%	-12.39%	-33.76%	-15.84%	52.27%
Net Cash Per Share	3.20	2.58	2.50	2.94	4.58	5.94
Filing Date Shares Outstanding	126.55	122.3	119.17	115.36	112.84	108.75
Total Common Shares Outstanding	126.54	122.29	119.1	115.2	112.51	108.49
Working Capital	512.5	466.75	468.86	504.08	637.23	656.24
Book Value Per Share	6.20	5.81	6.22	6.99	7.27	6.81
Tangible Book Value	715.85	689.95	719.92	778.37	787.66	716.72
Tangible Book Value Per Share	5.66	5.64	6.04	6.76	7.00	6.61
Land	36.77	36.77	36.77	36.78	36.1	-
Buildings	147.49	147.09	146.04	-	-	-
Machinery	102.19	97.04	96.6	76.87	62.69	41.68
Construction In Progress	2.53	5.15	7.25	153	52.19	19.59
Leasehold Improvements	89.37	89.57	96.41	91.52	67.53	42.07

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q